92 related articles for article (PubMed ID: 7717540)
1. Methemoglobinemia in a patient receiving flutamide.
Jackson SH; Barker SJ
Anesthesiology; 1995 Apr; 82(4):1065-7. PubMed ID: 7717540
[No Abstract] [Full Text] [Related]
2. Flutamide-induced methemoglobinemia.
Schott AM; Vial T; Gozzo I; Chareyre S; Delmas PD
DICP; 1991 Jun; 25(6):600-1. PubMed ID: 1877268
[TBL] [Abstract][Full Text] [Related]
3. Lack of methemoglobinemia with flutamide.
Schulz M; Schmoldt A; Donn F; Becker H
Ann Pharmacother; 2001 Jan; 35(1):21-5. PubMed ID: 11197580
[TBL] [Abstract][Full Text] [Related]
4. Flutamide induced methemoglobinemia.
Khan AM; Singh NT; Bilgrami S
J Urol; 1997 Apr; 157(4):1363. PubMed ID: 9120948
[No Abstract] [Full Text] [Related]
5. Experience with flutamide in previously untreated patients with advanced prostatic cancer.
Sogani PC; Whitmore WF
J Urol; 1979 Nov; 122(5):640-3. PubMed ID: 501817
[TBL] [Abstract][Full Text] [Related]
6. Interstitial pneumonitis related to flutamide monotherapy for prostate cancer.
Nomura M; Sato H; Fujimoto N; Matsumoto T
Int J Urol; 2004 Sep; 11(9):798-800. PubMed ID: 15379950
[TBL] [Abstract][Full Text] [Related]
7. Near fatal liver dysfunction secondary to administration of flutamide for prostate cancer.
Dankoff JS
J Urol; 1992 Dec; 148(6):1914. PubMed ID: 1433640
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced prostatic cancer with flutamide.
Sanford EJ; Bowditch RR; Rohner TJ; Bardin CW
Pa Med; 1979 Sep; 82(9):29-31. PubMed ID: 386212
[No Abstract] [Full Text] [Related]
9. [Fulminant hepatitis caused by flutamide].
Andréjak M; Nguyen-Khac E; Decocq G; Capron JP
Gastroenterol Clin Biol; 1996 Feb; 20(1):121-2. PubMed ID: 8734324
[No Abstract] [Full Text] [Related]
10. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer].
Patel H; Rhee E; Zimmern PE
J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557
[TBL] [Abstract][Full Text] [Related]
11. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.
Sogani PC; Vagaiwala MR; Whitmore WF
Cancer; 1984 Aug; 54(4):744-50. PubMed ID: 6378356
[TBL] [Abstract][Full Text] [Related]
12. [Use of flutamide in the treatment of carcinoma of the prostate stages C and D (T3-T4, Nx-N0, M0-M1 categories)].
Daricello G; Caramia G; Rizzo FP; Serretta V; Di Trapani D; Pavone-Macaluso M
Minerva Urol Nefrol; 1986; 38(1):71-6. PubMed ID: 3738681
[No Abstract] [Full Text] [Related]
13. Leuprolide with flutamide for complete androgen ablation: therapeutic alternative for advanced prostatic cancer (stage D2).
Chime-Udeh E
Conn Med; 1991 Sep; 55(9):526-8. PubMed ID: 1748007
[No Abstract] [Full Text] [Related]
14. Flutamide-induced acute renal failure in a patient with metastatic prostate cancer.
Altiparmak MR; Bilici A; Kisacik B; Ozguroglu M
Med Oncol; 2002; 19(2):117-9. PubMed ID: 12180480
[TBL] [Abstract][Full Text] [Related]
15. A new antiprostatic agent for treatment of prostatic carcinoma.
Irwin RJ; Prout GR
Surg Forum; 1973; 24():536-7. PubMed ID: 4806089
[No Abstract] [Full Text] [Related]
16. Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
Scher HI; Kelly WK
J Clin Oncol; 1993 Aug; 11(8):1566-72. PubMed ID: 7687666
[TBL] [Abstract][Full Text] [Related]
17. Effect of flutamide on cortisol metabolism.
Fukushima DK; Levin J; Kream J; Freed SZ; Whitmore WF; Hellman L; Zumoff B
J Clin Endocrinol Metab; 1978 Oct; 47(4):788-91. PubMed ID: 263325
[TBL] [Abstract][Full Text] [Related]
18. Flutamide in hormone-resistant prostatic cancer.
Fosså SD; Hosbach G; Paus E
J Urol; 1990 Dec; 144(6):1411-4. PubMed ID: 1700154
[TBL] [Abstract][Full Text] [Related]
19. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
[TBL] [Abstract][Full Text] [Related]
20. Photosensitive drug eruption induced by flutamide.
Yokote R; Tokura Y; Igarashi N; Ishikawa O; Miyachi Y
Eur J Dermatol; 1998 Sep; 8(6):427-9. PubMed ID: 9729061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
